Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: A mixed-method approach

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 11, 2013, Pages 1273-1281

  Maier, Franziska ^a   Lewis, Catharine J ^a   Horstkoetter, Nina ^b   Eggers, Carsten ^a   Kalbe, Elke ^a,c   Maarouf, Mohammad ^b   Kuhn, Jens ^b   Zurowski, Mateusz ^d   Moro, Elena ^e   Woopen, Christiane ^b   Timmermann, Lars ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF VECHTA   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885586081     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303670     Document Type: Article

References (46)

1. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908. (Pubitemid 44315982)
2. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7:605-14.
3. Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011;26:1022-31.
4. Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-7. (Pubitemid 27448379)
5. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry 2005;76:1188-93. (Pubitemid 41208365)
6. Schupbach M, Gargiulo M, Welter ML, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology 2006;66:1811-16. (Pubitemid 44049808)
7. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 2005;252:583-8. (Pubitemid 40768175)
8. Montel SR, Bungener C. Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Surg Neurol 2009;72:105-10; discussion 10-1.
9. Nisenzon AN, Robinson ME, Bowers D, et al. Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? Parkinsonism Relat Disord 2011;17:89-94.
10. Bell E, Mathieu G, Racine E. Preparing the ethical future of deep brain stimulation. Surg Neurol 2009;72:577-86; discussion 86.
11. Clausen J. Ethical brain stimulation-neuroethics of deep brain stimulation in research and clinical practice. Eur J Neurosci 2010;32:1152-62.
12. Sudmeyer M, Volkmann J, Wojtecki L, et al. Deep brain stimulation-expectations and doubts: a nationwide questionnaire study of patients with Parkinson's disease and their family members. Nervenarzt 2012;83:481-6.
13. Daniels C, Krack P, Volkmann J, et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? Mov Disord 2011;26:2516-21.
14. Smeding HM, Speelman JD, Huizenga HM, et al. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease. J Neurol Neurosurg Psychiatry 2011;82:754-60.
15. Soulas T, Sultan S, Gurruchaga JM, et al. Depression and coping as predictors of change after deep brain stimulation in Parkinson's disease. World Neurosurg 2011;75:525-32.
16. Witt K, Daniels C, Krack P, et al. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease. J Neurol Sci 2011;310:261-6.
17. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006;248:151-7. (Pubitemid 44647306)
18. Benito-Leon J, Cubo E, Coronell C. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study. Mov Disord 2012;27:211-18.
19. Hilker R, Benecke R, Deuschl G, et al. Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association. Nervenarzt 2009;80:646-55.
20. Kalbe E, Kessler J, Calabrese P, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004;19:136-43. (Pubitemid 38247848)
21. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
22. Mayring P. Qualitative content analysis. Forum: Qualitative Social Research, 2000;1(2).
23. Mayring P. Qualitative Inhaltsanalyse. Grundlagen und Techniken. Weinheim: Beltz, 2008.
24. Fahn S, Elton RL, Committee UD. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Floral Park, NY: MacMillan Healthcare Information, 1987:153-63.
25. Diener HC, Putzki N, eds. Leitlinien für Diagnostik und Therapie in der Neurologie. 4th edn. Stuttgart: Georg Thieme Verlag, 2008.
26. Härting C, Markowitsch HJ, Neufeld H, et al. WMS-R-Wechsler Gedächtnistest-revidierte Fassung. Bern: Huber, 2000.
27. Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortflüssigkeits- Test (RWT). Göttingen: Hogrefe, 2000.
28. Schretlen D, Bobholz JH, Brandt J. Development and psychometric properties of the brief test of attention. Clin Neuropsychologist 1996;10:80-9. (Pubitemid 26078604)
29. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991;38:143-62.
30. Beck AT, Steer RA, Ball R, et al. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996;67:588-97. (Pubitemid 26382973)
31. Shugar G, Schertzer S, Toner BB, et al. Development, use, and factor analysis of a self-report inventory for mania. Compr Psychiatry 1992;33:325-31.
32. Spielberger CD, Gorssuch RL, Lushene PR, et al. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Inc., 1983.
33. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011;68:165.
34. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:636-42. (Pubitemid 35448846)
35. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007;22:778-84. (Pubitemid 46800097)
36. Starkstein SE, Preziosi TJ, Bolduc PL, et al. Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31. (Pubitemid 20175041)
37. Starkstein S, Dragovic M, Jorge R, et al. Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Mov Disord 2011;26:2239-45.
38. Starkstein SE, Brockman S, Hayhow BD. Psychiatric syndromes in Parkinson's disease. Current opinion in psychiatry 2012;25:468-72.
39. Rodriguez RL, Fernandez HH, Haq I, et al. Pearls in patient selection for deep brain stimulation. Neurologist 2007;13:253-60. (Pubitemid 47396311)
40. Okun MS, Rodriguez RL, Foote KD, et al. A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders. Parkinsonism Relat Disord 2008;14:532-8.
41. Voon V, Saint-Cyr J, Lozano AM, et al. Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery. J Neurosurg 2005;103:246-51. (Pubitemid 43193899)
42. Kirsch-Darrow L, Marsiske M, Okun MS, et al. Apathy and depression: separate factors in Parkinson's disease. J Int Neuropsychol Soc 2011;17:1058-66.
43. Starkstein SE. Apathy in Parkinson's disease: diagnostic and etiological dilemmas. Mov Disord 2012;27:174-8.
44. Leentjens AF, Dujardin K, Marsh L, et al. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008;23:2004-14.
45. Visser M, Leentjens AF, Marinus J, et al. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord 2006;21:668-72. (Pubitemid 43792748)
46. Woopen C, Timmermann L, Kuhn J. An ethical framework for outcome assessment in psychiatric DBS. AJOB Neuroscience 2012;3:50-5.